|
Market Cap (13-Jul) $6,957,488 (1,468th) |
Close (30-Jun) $0.042 |
Volume (30-Jun) 582,113 |
Shortsold (6-Dec) 611,822 (0.21%) (374th) |
|
52w High $0.079 |
52w Low $0.015 |
P/E - |
EPS -0.02 |
ACR released this announcement to the ASX on 21 October 2022, 8:21. The announcement is not marked as price sensitive, and is 17 page(s) in length and 576.13kb in size.
You can view all announcements from ACR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ACR was 0.004% short sold according to ASIC data. It was ranked the 605th most shorted stock on the ASX. It is now ranked as the 374th most shorted stock on the ASX with 0.210% of total shares short sold as of the latest reported data (06 December 2024).
| Other Recent Announcements from ACR | |
|---|---|
| Appendix 3Y Brooke | 16 June 2023, 9:27 |
| Application for quotation of securities - ACR | 16 June 2023, 9:25 |
| 4th FDA ANDA approval received - Dapsone Gel, 5% | 7 June 2023, 10:35 |
| Notice of Annual General Meeting/Proxy Form | 21 October 2022, 8:21 |
| Application for quotation of securities - ACR | 17 October 2022, 9:05 |
| Remaining balance of R&D Tax Incentive Rebate received | 3 October 2022, 9:32 |
| R&D Tax Incentive Rebate received | 26 September 2022, 9:48 |
You must be logged in to post a reply.
